Wei Niu

2.8k total citations · 1 hit paper
71 papers, 2.2k citations indexed

About

Wei Niu is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Wei Niu has authored 71 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 18 papers in Pharmacology and 16 papers in Oncology. Recurrent topics in Wei Niu's work include Pharmacological Effects of Natural Compounds (11 papers), Ginseng Biological Effects and Applications (6 papers) and Gut microbiota and health (6 papers). Wei Niu is often cited by papers focused on Pharmacological Effects of Natural Compounds (11 papers), Ginseng Biological Effects and Applications (6 papers) and Gut microbiota and health (6 papers). Wei Niu collaborates with scholars based in China, United States and Czechia. Wei Niu's co-authors include Feifei Du, Junling Yang, F. Xu, Feng‐Qing Wang, Chuan Li, Jianming Ju, Yühong Huang, Zhenhai Zhang, Li Li and Shuting Li and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Wei Niu

69 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors

2016 332 citations Wei Niu, Feng‐Qing Wang et al. profile →

Peers

Countries citing papers authored by Wei Niu

Since Specialization

Citations

This map shows the geographic impact of Wei Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Niu more than expected).

Fields of papers citing papers by Wei Niu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Niu. The network helps show where Wei Niu may publish in the future.

Co-authorship network of co-authors of Wei Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Niu. A scholar is included among the top collaborators of Wei Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Niu. Wei Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Icariin-based bone scaffold for treating steroid-induced necrosis of femoral head by restoring angiogenesis and promoting osteogenesis 2025 ·Materials & Design ·(unknown), (unknown), (unknown), Wei Niu, Xulin Hu	1
2	Degradation of xylan by human gut Bacteroides xylanisolvens XB1A 2023 ·Carbohydrate Polymers ·Tingting Zhao, Han Yue, (unknown), (unknown), (unknown), Tingting Li, Wei Niu, Chuan Li, Zhengqing Zhang, Meixia Li, Kan Ding	17
3	Tanshinone I attenuates estrogen-deficiency bone loss via inhibiting RANKL-induced MAPK and NF-κB signaling pathways 2023 ·International Immunopharmacology ·Chao Ma, (unknown), (unknown), (unknown), Guangquan Zhou, Chunzhi Yi, Wei Niu, Yuhao Liu	8
4	Benzothiozinone derivatives with anti-tubercular Activity−Further side chain investigation 2023 ·European Journal of Medicinal Chemistry ·(unknown), Wenxin Wang, Giovanni Stelitano, Olga Riabova, Bin Wang, Wei Niu, (unknown), Rui Shi, Laurent R. Chiarelli, Vadim Makarov, Yu Lu, Chuan Li, Chunhua Qiao	4
5	The combination of sodium alginate and chlorogenic acid enhances the therapeutic effect on ulcerative colitis by the regulation of inflammation and the intestinal flora 2022 ·Food & Function ·Wei Niu, Yuxuan Chen, Ligui Wang, (unknown), (unknown), (unknown), (unknown), Jiege Huo, Zhenhai Zhang, Jianming Ju	16
6	The role of enteric dysbacteriosis and modulation of gut microbiota in the treatment of inflammatory bowel disease 2021 ·Microbial Pathogenesis ·Wei Niu, (unknown), (unknown), (unknown), Zhenhai Zhang, Jianming Ju	30
7	Identification of integrin β6 gene promoter and analysis of its transcription regulation in colon cancer cells 2020 ·World Journal of Gastrointestinal Oncology ·Wei Niu, (unknown), Jun Niu, Zhengchuan Niu, Peng Cheng, Xueqing Zou, Zhaoyang Zhang	3
8	Comparison of intramuscular and intravenous pharmacokinetics of ginsenosides in humans after dosing XueShuanTong, a lyophilized extract of Panax notoginseng roots 2020 ·Journal of Ethnopharmacology ·Haiyan Zhang, Wei Niu, Olajide E. Olaleye, Feifei Du, (unknown), Yühong Huang, Lei Yuan, Yanfen Li, (unknown), Fang Xu, Junling Yang, Chuan Li	17
9	Isolation of Circulating Tumor Cells of Ovarian Cancer by Transferrin Immunolipid Magnetic Spheres and Its Preliminary Clinical Application 2019 ·Nano LIFE ·Li Zuo, Wei Niu, Anqi Li	3
10	Pharmacokinetics and disposition of anlotinib, an oral tyrosine kinase inhibitor, in experimental animal species 2018 ·Acta Pharmacologica Sinica ·Chenchun Zhong, Feng Chen, Junling Yang, Weiwei Jia, Li Li, Chen Cheng, Feifei Du, Suping Zhang, Chengying Xie, (unknown), Olajide E. Olaleye, (unknown), Fang Xu, Liguang Lou, Dongying Chen, Wei Niu, Chuan Li	56
11	Molecular mechanisms governing different pharmacokinetics of ginsenosides and potential for ginsenoside‐perpetrated herb–drug interactions on OATP1B3 2014 ·British Journal of Pharmacology ·Rongrong Jiang, Jiajia Dong, Xiuxue Li, Feifei Du, Weiwei Jia, F. Xu, Fengqing Wang, Junling Yang, Wei Niu, Chuan Li	56
12	Dissection of a Circulating and Intrahepatic CD4+Foxp3+ T-Cell Subpopulation in Chronic Hepatitis B Virus (HBV) Infection: A Highly Informative Strategy for Distinguishing Chronic HBV Infection States 2012 ·The Journal of Infectious Diseases ·Mengjun Zhang, (unknown), Tingting Zhao, (unknown), (unknown), (unknown), Xiaolan Fu, Wei Niu, Gang Meng, Xiaoling Chen, Xiaoyun Shang, (unknown), Bing Ni, (unknown), Yuzhang Wu	21
13	Metabolic capabilities of cytochrome P450 enzymes in Chinese liver microsomes compared with those in Caucasian liver microsomes 2011 ·British Journal of Clinical Pharmacology ·Junling Yang, Minxia M. He, Wei Niu, Steven Wrighton, Li Li, Yang Liu, Chuan Li	43
14	Oral bioavailability and brain penetration of (−)‐stepholidine, a tetrahydroprotoberberine agonist at dopamine D₁ and antagonist at D₂ receptors, in rats 2009 ·British Journal of Pharmacology ·Yan Sun, Jieyu Dai, Zheyi Hu, Feifei Du, Wei Niu, Feng‐Qing Wang, Fei Liu, Guo-Zhang Jin, Chuan Li	26
15	Rational optimization of tumor epitopes using in silico analysis‐assisted substitution of TCR contact residues 2009 ·European Journal of Immunology ·Xiaoyun Shang, Li Wang, Wei Niu, Gang Meng, Xiaolan Fu, Bing Ni, (unknown), Zhao Yang, Xiaolin Chen, Yuzhang Wu	8
16	Absorption and Disposition of Ginsenosides after Oral Administration of Panax notoginseng Extract to Rats 2009 ·Drug Metabolism and Disposition ·Houfu Liu, Junling Yang, Feifei Du, Xiumei Gao, (unknown), Yühong Huang, F. Xu, Wei Niu, Fengqing Wang, Yu Mao, Yan Sun, Tong Lu, Changxiao Liu, Boli Zhang, Chuan Li	319
17	Anti-HBV agents. Part 3: Preliminary structure–activity relationships of tetra-acylalisol A derivatives as potent hepatitis B virus inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Quan Zhang, Zhiyong Jiang, (unknown), Yun‐Bao Ma, (unknown), Ruihua Guo, Xue‐Mei Zhang, Jun Zhou, Wei Niu, Feifei Du, Li Li, Chuan Li, Ji‐Jun Chen	19
18	A novel mimovirus vaccine containing survivin epitope with adjuvant IL-15 induces long-lasting cellular immunity and high antitumor efficiency 2007 ·Molecular Immunology ·Zhao Yang, Li Wang, Huiming Wang, Xiaoyun Shang, Wei Niu, Jintao Li, Yuzhang Wu	26
19	‘LC‐electrolyte effects’ improve the bioanalytical performance of liquid chromatography/tandem mass spectrometric assays in supporting pharmacokinetic study for drug discovery 2007 ·Rapid Communications in Mass Spectrometry ·Li Wang, Yan Sun, Feifei Du, Wei Niu, Tong Lu, (unknown), Fang Xu, (unknown), Tao Qin, Changxiao Liu, Chuan Li	23
20	Purification and characterization of an antimicrobial protein from seeds of Ginkgo biloba 2003 ·Xibei zhiwu xuebao ·Wei Niu	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact